For: | Wu HC, Shen J, Yang HI, Tsai WY, Chen CJ, Santella RM. Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan. World J Hepatol 2016; 8(5): 301-306 [PMID: 26925204 DOI: 10.4254/wjh.v8.i5.301] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i5/301.htm |
Number | Citing Articles |
1 |
Megan Beetch, Katarzyna Lubecka, Heather Kristofzski, Matthew Suderman, Barbara Stefanska. Subtle Alterations in DNA Methylation Patterns in Normal Cells in Response to Dietary Stilbenoids. Molecular Nutrition & Food Research 2018; 62(14) doi: 10.1002/mnfr.201800193
|
2 |
Martin Widschwendter, Allison Jones, Iona Evans, Daniel Reisel, Joakim Dillner, Karin Sundström, Ewout W. Steyerberg, Yvonne Vergouwe, Odette Wegwarth, Felix G. Rebitschek, Uwe Siebert, Gaby Sroczynski, Inez D. de Beaufort, Ineke Bolt, David Cibula, Michal Zikan, Line Bjørge, Nicoletta Colombo, Nadia Harbeck, Frank Dudbridge, Anne-Marie Tasse, Bartha M. Knoppers, Yann Joly, Andrew E. Teschendorff, Nora Pashayan. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nature Reviews Clinical Oncology 2018; 15(5): 292 doi: 10.1038/nrclinonc.2018.30
|
3 |
Katarzyna Lubecka, Kirsty Flower, Megan Beetch, Jay Qiu, Lucinda Kurzava, Hannah Buvala, Adam Ruhayel, Samer Gawrieh, Suthat Liangpunsakul, Tracy Gonzalez, George McCabe, Naga Chalasani, James M Flanagan, Barbara Stefanska. Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development. Epigenetics 2018; 13(6): 605 doi: 10.1080/15592294.2018.1481706
|
4 |
Xiang-Yong Hao, An-Qiang Li, Hao Shi, Tian-Kang Guo, Yan-Fei Shen, Yuan Deng, Li-Tian Wang, Tao Wang, Hui Cai. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma. Bioscience Reports 2021; 41(3) doi: 10.1042/BSR20203945
|